Alteration in Plasma Total Antioxidant Capacity, Cardiotoxic Lipid Peroxidation Product and C-Reactive Protein: A Possible Explantation for the Increased Cardiovascular Risk in Children on Hemodialysis

Elshamaa MF; Sabry S; Nabih M; Elghoroury EA; El-Saaid GS; Ismail AAG

Elshamaa MF, Sabry S, Nabih M, Elghoroury EA, El-Saaid GS, Ismail AAG
Alteration in Plasma Total Antioxidant Capacity, Cardiotoxic Lipid Peroxidation Product and C-Reactive Protein: A Possible Explantation for the Increased Cardiovascular Risk in Children on Hemodialysis
Journal of Clinical and Basic Cardiology 2008; 11 (1-4): 2-7

PDF Summary Overview

Figure/Graphic 1: TAC - MDA
Serum total antioxidant capacity (TAC) (a) and malondialdehyde (MDA) (b) levels in hemodialyzed patients (HD) and in normal individuals. Columns represent mean ± SD.

Previous Image

Next Image

Figure/Graphic 1: TAC - MDA
Serum total antioxidant capacity (TAC) (a) and malondialdehyde (MDA) (b) levels in hemodialyzed patients (HD) and in normal individuals. Columns represent mean ± SD.